These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5737 related articles for article (PubMed ID: 3180746)

  • 1. A method for determining the optimum transform for covariates of the Cox model with application to 3680 cases of intraocular melanoma.
    Gamel JW; McLean IW
    Comput Biomed Res; 1988 Oct; 21(5):471-7. PubMed ID: 3180746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for assessing potential bias among cancer patients recorded as "dead of other causes." Application to cases of intraocular melanoma.
    Gamel J; Seddon J; Polivogianis L; Albert D; Greenberg R
    Cancer; 1986 Jun; 57(11):2246-9. PubMed ID: 3697925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stable linear algorithm for fitting the lognormal model to survival data.
    Gamel JW; Greenberg RA; McLean IW
    Comput Biomed Res; 1988 Feb; 21(1):38-47. PubMed ID: 3345651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excision.
    Gamel JW; McLean IW; Greenberg RA
    Cancer; 1988 Feb; 61(3):574-9. PubMed ID: 3338025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling survival after treatment of intraocular melanoma using artificial neural networks and Bayes theorem.
    Taktak AF; Fisher AC; Damato BE
    Phys Med Biol; 2004 Jan; 49(1):87-98. PubMed ID: 14971774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of eye tumors by accelerated proton beams. 7 years experience].
    Zografos L; Bercher L; Egger E; Chamot L; Gailloud C; Uffer S; Perret C; Markovits C
    Klin Monbl Augenheilkd; 1992 May; 200(5):431-5. PubMed ID: 1319524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival after complete resection of metastases from intraocular melanoma.
    Rivoire M; Kodjikian L; Négrier S
    Cancer; 2004 Jul; 101(1):207-8; author reply 208. PubMed ID: 15222009
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival rates after enucleation of eyes with malignant melanoma.
    Seigel D; Myers M; Ferris F; Steinhorn SC
    Am J Ophthalmol; 1979 Jun; 87(6):761-5. PubMed ID: 453304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma female/male death ratios.
    Lee JA; Storer BE
    Lancet; 1981 Jun; 1(8235):1419. PubMed ID: 6113371
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraocular metastases from cutaneous malignant melanoma.
    de Bustros S; Augsburger JJ; Shields JA; Shakin EP; Pryor CC
    Arch Ophthalmol; 1985 Jul; 103(7):937-40. PubMed ID: 4015484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular melanoma in Alberta: a 38 year review pointing to the importance of tumor size and tumor histology as predictors of survival.
    Hayton S; Lafreniere R; Jerry LM; Temple WJ; Ashley P
    J Surg Oncol; 1989 Dec; 42(4):215-8. PubMed ID: 2593663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular melanoma.
    Gamel JW
    Arch Ophthalmol; 1985 Sep; 103(9):1284. PubMed ID: 4038120
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of epidemiological investigations in the study of ocular tumors.
    Smith AB; Egan EA
    Int Ophthalmol Clin; 1980; 20(2):63-9. PubMed ID: 6995392
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical methods for the practical clinical application of morphometric measurements.
    Gamel JW; McLean IW; Greenberg R
    Anal Quant Cytol Histol; 1987 Mar; 9(1):30-8. PubMed ID: 3555534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar survival rates for ocular melanoma therapies.
    Optom Vis Sci; 2001 Sep; 78(9):626. PubMed ID: 11587196
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of primary intraocular melanoma.
    Damato B
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):493-506. PubMed ID: 16613538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation.
    Zimmerman LE; McLean IW; Foster WD
    Ophthalmology; 1980 Jun; 87(6):557-64. PubMed ID: 7413145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low thyroid hormone levels improve survival in murine model for ocular melanoma.
    Fabian ID; Rosner M; Fabian I; Vishnevskia-Dai V; Zloto O; Shinderman Maman E; Cohen K; Ellis M; Lin HY; Hercbergs A; Davis PJ; Ashur-Fabian O
    Oncotarget; 2015 May; 6(13):11038-46. PubMed ID: 25868390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 287.